News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
106last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.95d agoneutral
Amgen (AMGN) Lifted 2026 Guidance, Is The Valuation Still Too Rich?GuruFocus.com95d agobullish
Amgen Inc (AMGN) (Q2 2026) Earnings Call Highlights: Revenue Surges Past $10 Billion, Guidance ...The Wall Street Journal96d agoneutral
Amgen Lifts Outlook on Strong Drug Sales, to End Early Development of Obesity TreatmentInvestor's Business Daily96d agoneutral
Amgen Hikes Sales Outlook By $1 Billion After Second-Quarter SmashBarrons.com102d agoneutral
Biogen Raises Revenue Guidance as Growth Portfolio Outpaces Legacy Blockbuster DrugsInvestor's Business Daily115d agobullish
Dow Jones' Merck Snags A First-Of-Its-Kind Approval, And JumpsSimply Wall St.124d agobearish
Did Enbrel’s Price Cap Reprieve and New Recalls Just Rebalance Amgen’s (AMGN) Risk‑Reward Profile?Simply Wall St.124d agobearish
Amgen (AMGN) Recalls Sensipar And Corlanor In Broad US Quality Sweep